1. -
API - Product List
S. No. Product Innovator’s Product Details DMF status
Brand Name
1 Aliskiren Hemifumerate Tekturna Renin inhibitor --
2 Atorvastatin Calcium Amorphous Lipitor Chloesterol Lowering USDMF, EDMF
3 Atorvastatin Calcium Crystalline Lipitor Chloesterol Lowering USDMF, EDMF
4 Desloratadine Clarinex Antihistaminic USDMF, EDMF
5 Eletriptan hydrobromide Relpax Antimigraine --
6 Ezetimibe Zetia Antihyperlipoproteinemic --
7 Fexofenadine Hydrochloride Allegra Antihistaminic EDMF
8 Linezolid Zyvox Antibacterial Tech. Package
9 Loratadine Claritin Antihistaminic USDMF, CEP
10 Montelukast Sodium Singulair Antiasthmatic EDMF
11 Paracetamol Tylenol Antipyretic Tech Package
12 Pioglitazone Hydrochloride Actos Antidiabetic USDMF, EDMF
13 Prasugrel Effient Platelet inhibitor --
14 Rosuvastatin Calcium Crestor Antihyperlipoproteinemic;HM --
G CoAReductase Inhibitor
15 Telmisartan Micardis Antihypertensive Tech. Pacakage
16 Valsartan Tereg Antihypertensive, --
Biphenyltetrazole derivatives
17 Voglibose Basen Antidiabetic Under development
Note: The above products are not for sale where the Patents are applicable & still valid.
Intermediates-Product List
S. No. Product Chemical Name of Intermediate Intermediate CAS No.
Code
1 Montelukast Methyl-[E]-3-[3-[2-(7-chloro-2-quinolinyl) ethenyl] MTN6 149968-11-6
phenyl]-3-oxo-propyl]benzoate
Methyl-[E]-2-[3S-[3-[2-(7-chloro-2-quinolinyl) ethenyl] MT7 181139-72-0

2. phenyl] -3-hydroxy propyl] benzoate
[(S)-(E)]-2-[3-[3-[2-(7-chloro-2-quinolinyl) ethenyl] phenyl] MT8 142569-70-8
-3-hydroxypropyl]-phenyl-2-propanol
1-(hydroxymethyl)cyclopropyl acetonitrile MTS2 152922-71-9
1-(Mercaptomethyl) cyclopropane acetic acid MTS4 162515-68-6
(1-mercaptomethyl) cyclopropane methyl acetate MTS5 152922-73-1
2 Loratadine 2-Cyano-3-(3-chlorophenethyl)pyridine L5 31255-57-9
8-Chloro-10, 11-dihydro-4-aza-5H-dibenzo (a, d) L7 31251-41-9
cycloheptan-5-one
(1-Methyl-4-piperidinyl)[3-(2-3-chlorophenyl)ethyl-2- LN8 130642-50-1
pyridinyl] methanone hydrochloride
11-(N-Methyl-4-piperidinyl)-8-chloro-11-hydroxy- 6,11- L8 38089-93-9
dihydro-5H-benzo(5,6)cyclohepta (1,2-b) pyridine
11-(N-Methyl-4-piperidinylidene)-8-chloro-6,11- L9 / LH9 38092-89-6
dihydro-5H-benzo(5,6)cyclohepta (1,2-b) pyridine
3 Fexofenadine 4-(cyclopropylcarbonyl)-α,α-dimethyl benzene acetic acid D8 162096-54-0
2-(4-(4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)-1- D10 or FD3 154477-55-1
oxobutyl)phenyl)-2,2-dimethylacetic acid methyl ester
4 Carvedilol 4-(2,3-Epoxypropoxy)carbazole CD3 51997-51-4
5 Lamotrigine 2-(2,3-Dichlorophenyl)-2-(guanidinyamino)acetonitrile LMG01 84689-20-3
6 Pioglitazone (±)5-{4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl}-2-imino-4- PG4 105355-26-8
thiazolidinone
5-{4-[2-(5-Ethyl-2-pyridinyl)ethoxyl]benzyldene}-2,4- PGN3 144809-28-9
thiazolidinedione
7 Telmisartan 2n-Propyl-4-methyl-6-(1-methyl benzimidazole-2-yl)- TL06 152628-02-9
benzimidazole
8 Risperidone 3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H- RB03 93076-03-0
pyrido[1,2-a]pyrimidin-4-one hydrochloride
6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole RA04 84163-13-3
hydrochloride
9 Linezolid (R)-N-[[3-[3-fluoro-4-morphonilyl]phenyl]-2-oxo-5- LZ04 168828-82-8
oxazolidinyl]methanol
(R)-N-[[3-[3-fluoro-4-morphonilyl]phenyl]-2-oxo-5- LZ06 168828-84-0
oxazolidinyl]azide
(R)-N-[[3-[3-fluoro-4-morphonilyl]phenyl]-2-oxo-5- LZ07A Not Available
oxazolidinyl] methyl amine
10 Atorvastatin 4-Fluoro-Alpha-[2-methyl-1-oxopropyl]-Gamma-oxo-N- AT-3 125971-96-2
Beta-diphenyl benzene Butanamide
(4R-Cis)-1,1-Dimethylethyl-6-cyanomethyl-2,2- AT-6 125971-96-2
dimethyl-1,3-Dioxane -4-Acetate
(4R-Cis)-1,1-Dimethylethyl-6-[2-[2-(4-Fluorophenyl)-5-(1-
Isopropyl)-3-phenyl-4-[(Phenylamino)carbonyl]1H-
pyrrol-1-yl]Ethyl]-2,2-Dimethyl-1,3-Dioxane-4-Acetate AT-8 125971-95-1
11 Aliskiren (R)-4-(2-(chloromethyl)-3-methylbutyl) -1-methoxy-2-(3- AL06 324763-39-5
methoxypropoxy)benzene
3-isovaleroyl-4(R)-benzyl-oxazolidin-2-one ALS01 145589-03-3
12 Rosuvastatin 4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-N- RT08 147118-37-4
methylsulfonyl) amino]pyrimidinyl-5-yl-carbaldehyde
13 Quetiapine Dibenzo[b,f] [1,4]thiazepine-11(10H) one QT02 3159-07-7
14 Eletriptan 5-Bromo-3-(N-methylpyrrolidin-2(R)–yl methyl)-1H-indole EL03 143322-57-0

3. Note: The above intermediates are not for sales where the Patents are applicable & still valid.
Intermediates under Development
S. No. Product Name Stage CAS No. Chemical Name
1 Aliskiren ALN01 173336-76-0 4-Bromo-1-methoxy-2(3-methoxypropoxy) benzene
ALN07 Not Available (2S,7S)-2-isopropyl-7-{4-methoxy-3-(3-
methoxypropoxy)bezyl}-8-methylnonayl-N,N-
dimethylformamide
ALN08 Not Available (S)-2-[(S)-2-bromo-2-((2R,4S)-4-isopropyl-5-oxo-
tetrahydrofuran-2-yl)-ethyl-1-[3-(3-methoxy propoxy)-4-
methylphenyl] -3-methylbutyl ester
ALN10 Not Available (2S,4S,5S,7S)-5-azido-4-hydroxy-2-isopropy-7-[4-
methoxypropoxy)-benzyl]-8-methyl nonanic acid (2-
carbamoyl-2-methyl propyl) amide
AL10 Not Available 2(S)-(tert-butoxycarbonyl)amino-4(S)-isopropyl-5-(p-tert-
butyl-phenyl)-pentanal.
2 Ezetimibe EB02 Not Available (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxy pentanoyl]-4-
phenyl-1,3- oxazolidin-2-one
EB03 Not Available (S)-3-{(R)-2-[(S)-4-(trimethylsilyloxy)-phenyl]-(4-
fluorophenylamine)-methyl -4-[2-(4-fluorophenyl)-(1S)-
trimethyl silyloxy]-butyric}-4-phenyl-oxazolidine-2-one

4. EB04 Not Available (3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-
(4-fluorophenyl)-3-(trimethylsilyloxy) propyl]-4-(4-
(trimethylsilyloxy)phenyl)-2-azetidinone
EZ04 Not Available (3R,4S)-1-(4-Fluorophenyl)-3-[3-(hydroxy)-3-
oxopropyl]-4-(4-benzyloxyphenyl)-2-azetidonone
3 Eletriptan EL06 Not Available 5-[2-(Benzene sulfonyl)ethenyl]-3-(1-methyl
pyrrolidin-2(R)yl methyl)-1H-indole
4 Linezolid LZN04 Not Available (5R)-5-(chloromethyl)-3-[3-fluoro-4-(4-
morpholinyl)phenyl]-2-oxazolidinone
LZN05 Not Available (S)-N-[[3-[3-Fluoro-4-[4-morpholinyl]phenyl]-2-oxo-5-
oxazolidinyl]methyl]pthalamide
5 Quetiapine QTS01 13349-82-1 1-[2-(2-Hydroxyethoxy) ethyl]piperazine
6 Valsartan -- 195435-23-5 (R)-3-Methyl-2-(N-((2`-(2-trityl -2H-tetrazol-5-
yl)biphenyl-4-yl) methyl)pentananamido) butanoic acid
OR Trityl valsartan
-- 137863-20-8 N-[2`-(1H-tetrazol-5-yl)biphenyl-4-yl methyl]-N-Valeryl-
(L)-valine benzyl ester OR Valsartan benzyl ester
7 Ziprasidone Int -I 118289-55-7 5-(2-chloroethyl)-6-chlorooxindole
Int - II 144010-02-6 3-(1-Piperazinyl)-1,2- benzisothiazole hydrochloride
Note: The above intermediates are not for sales where the Patents are applicable & still valid.